Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1Classical hematology 1

Conditions

Melanoma 1Anemia, Iron-Deficiency 1Anemia 1

Interventions

Peripheral Blood Stem Cell Transplantation 4fludarabine phosphate 2Whole-Body Irradiation 2Methotrexate 2Cyclosporine 2Cyclophosphamide 2Busulfan 2siltuximab 1pegylated granulocyte colony-stimulating factor 1magrolimab 1hetrombopag 1fludarabine 1ferric gluconate 1decitabine and cedazuridine drug combination 1ceftolozane, tazobactam drug combination 1avatrombopag 1Transplantation 1Tacrolimus 1Radiotherapy 1Pluvicto 1Pentostatin 1Mycophenolic Acid 1Micafungin 1Meropenem 1Iron-Dextran Complex 1Iron 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Holistic Health 1Genotype 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Iron-Dextran Complex × Classical hematology × Clear all
NCT06508827 2025-07-09

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

Indiana University

Phase 2 Withdrawn
Classical hematologyDermatologic

Anemia, Melanoma, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡